Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H3.5 is a human-specific, non-allelic variant of histone H3, encoded by the H3-5 (H3F3C) gene, and is evolutionarily derived from H3.3[2][4]. It functions as a core component of nucleosomes, which organize genomic DNA into chromatin and regulate its accessibility for transcription, replication, and repair[4]. H3.5 is distinguished by several amino acid substitutions compared to canonical H3.3, notably Leu103, which renders nucleosomes containing H3.5 less stable than those with H3.3[2]. This instability is believed to contribute to dynamic chromatin regions, particularly around transcription start sites (TSSs) in the testis, where H3.5 accumulates and may modulate gene expression during spermatogenesis[2]. Unlike most histone genes, H3-5 is polyadenylated and contains introns[4]. H3.5 colocalizes with euchromatin and is preferably associated with active genes[4]. Although there are associations with glioma, no direct drug interactions, biomarker uses, or defined therapeutic targeting roles are established for H3.5[4]. Its primary relevance is in chromatin biology and testis-specific gene regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H3.5 (H3.5).